Stephen Elledge headshot

Stephen J. Elledge, Ph.D.

Gregor Mendel Professor of Genetics and of Medicine, Brigham and Women's Hospital
Professor of Medicine, Brigham and Women's Hospital
T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics.
Authors: Authors: Abdelfattah NS, Kula T, Elledge SJ.
Immunity
View full abstract on Pubmed
Structural basis for C-degron selectivity across KLHDCX family E3 ubiquitin ligases.
Authors: Authors: Scott DC, Chittori S, Purser N, King MT, Maiwald SA, Churion K, Nourse A, Lee C, Paulo JA, Miller DJ, Elledge SJ, Harper JW, Kleiger G, Schulman BA.
Nat Commun
View full abstract on Pubmed
Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2.
Authors: Authors: Scott DC, Dharuman S, Griffith E, Chai SC, Ronnebaum J, King MT, Tangallapally R, Lee C, Gee CT, Yang L, Li Y, Loudon VC, Lee HW, Ochoada J, Miller DJ, Jayasinghe T, Paulo JA, Elledge SJ, Harper JW, Chen T, Lee RE, Schulman BA.
Nat Commun
View full abstract on Pubmed
Dipeptidyl peptidases and E3 ligases of N-degron pathways cooperate to regulate protein stability.
Authors:
J Cell Biol
View full abstract on Pubmed
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of a-synuclein inclusions.
Authors: Authors: Lam I, Ndayisaba A, Lewis AJ, Fu Y, Sagredo GT, Kuzkina A, Zaccagnini L, Celikag M, Sandoe J, Sanz RL, Vahdatshoar A, Martin TD, Morshed N, Ichihashi T, Tripathi A, Ramalingam N, Oettgen-Suazo C, Bartels T, Boussouf M, Schäbinger M, Hallacli E, Jiang X, Verma A, Tea C, Wang Z, Hakozaki H, Yu X, Hyles K, Park C, Wang X, Theunissen TW, Wang H, Jaenisch R, Lindquist S, Stevens B, Stefanova N, Wenning G, van de Berg WDJ, Luk KC, Sanchez-Pernaute R, Gómez-Esteban JC, Felsky D, Kiyota Y, Sahni N, Yi SS, Chung CY, Stahlberg H, Ferrer I, Schöneberg J, Elledge SJ, Dettmer U, Halliday GM, Bartels T, Khurana V.
Neuron
View full abstract on Pubmed
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer.
Authors: Authors: Hillis AL, Martin TD, Manchester HE, Högström J, Zhang N, Lecky E, Kozlova N, Lee J, Persky NS, Root DE, Brown M, Cichowski K, Elledge SJ, Muranen T, Fruman DA, Barry ST, Clohessy JG, Madsen RR, Toker A.
Cancer Res
View full abstract on Pubmed
High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits.
Authors:
Nat Biotechnol
View full abstract on Pubmed
Proteasomal control of anti-CRISPRs for the regulation of CRISPR/Cas9 activity using Cas9-ACROBAT.
Authors: Authors: Martin TD, Watson EV, Choi MY, Nabet B, Gray NS, Xu Q, Elledge SJ.
bioRxiv
View full abstract on Pubmed
Mechanism of ?-Pro/C-degron recognition by the CRL2FEM1B ubiquitin ligase.
Authors: Authors: Chen X, Raiff A, Li S, Guo Q, Zhang J, Zhou H, Timms RT, Yao X, Elledge SJ, Koren I, Zhang K, Xu C.
Nat Commun
View full abstract on Pubmed
Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
Authors: Authors: Cortese M, Leng Y, Bjornevik K, Mitchell M, Healy BC, Mina MJ, Mancuso JD, Niebuhr DW, Munger KL, Elledge SJ, Ascherio A.
JAMA Neurol
View full abstract on Pubmed